comparemela.com

Latest Breaking News On - Biotechnology services - Page 5 : comparemela.com

Healthcare Stocks Are Priced for a Fire Sale These 6 Funds Can Ride Them Higher

Actively managed mutual funds make sense when investing in healthcare, since companies’ future prospects are often difficult for the market to price.

Eli lillyMichael maguireRebecca sykesNeal kaufmanZiad bakriRandy ackerT rowe price health sciencesJanus henderson global life sciencesNovo nordiskVanguard health careBaron health carePutnam global health careFund tickerHealth careHenderson global life sciencesGlobal health care

Regeneron Gets FDA Priority Review of Linvoseltamab in Multiple Myeloma

By Colin Kellaher Regeneron Pharmaceuticals has won U.S. Food and Drug Administration priority review for its application seeking approval of linvoseltamab.

Colin kellaherRegeneron pharmaceuticalsDrug administrationArticle normalBiotechnology servicesHealthcare life sciencesRegulation government policyNew products servicesProduct service approvalsCorporate industrial newsProducts servicesPolitical general newsMedical conditionsContent typesFactiva filtersC amp ampe industry news filter

SolarEdge Stock Tumbles After Earnings The Outlook Is Getting Gloomier

SolarEdge stock plunged early Wednesday as revenue tumbled in the fourth quarter and the company issued a gloomier-than-expected outlook.

United statesCanaccord genuityAustin moellerCallum keownFrederick florinSophie karpEnphase energyFederal reserveGetty imagesEdge technologiesBanc capital marketsSector weightWall streetFirst solarArticle normalBiotechnology services

RAPT Therapeutics stock plunges as FDA halts two clinical trials

RAPT Therapeutics shares dropped more than 60% premarket on Tuesday after the company said regulators have hit pause on two clinical trials of its.

Brian wongRapt therapeutics incDrug administrationGoldman sachsArticle normalBiotechnology servicesComputers consumer electronicsApplications softwareHealthcare life sciencesRegulation government policyNew products servicesResearch developmentCorporate industrial newsProducts servicesNew product service testingPolitical general news

Monopar Therapeutics Shares Surge on Australia Antibody-Trial Clearance

By Sabela Ojea Shares of Monopar Therapeutics on Tuesday rose sharply after the company said it received clearance in Australia to begin a phase 1 dosimetry.

Sabela ojeaMonopar therapeuticsArticle normalBiotechnology servicesScientific research servicesHealthcare life sciencesBusiness consumer servicesMedical research servicesDrug discovery developmentHealthcare support servicesDiagnostic medical research servicesFinancial performanceShare price movement disruptionsCorporate industrial newsContent typesFactiva filters

vimarsana © 2020. All Rights Reserved.